Vanholder et al., 2008 - Google Patents

From uremic toxin retention to removal by convection: do we know enough?

Vanholder et al., 2008

Document ID
12770431737179743860
Author
Vanholder R
Meert N
Schepers E
Glorieux G
Publication year
Publication venue
Hemodialysis-From Basic Research to Clinical Trials

External Links

Snippet

The uremic syndrome is defined by a complex clinical picture, characterized by the dysfunction of most organs which are affected by the retention of multiple solutes. Recent research has helped to unravel the pathophysiology and to identify several as yet unknown …
Continue reading at karger.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Similar Documents

Publication Publication Date Title
Vanholder et al. What is new in uremic toxicity?
Fagugli et al. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis
Butt et al. A molecular mechanism explaining albuminuria in kidney disease
Lesaffer et al. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane
Vanholder et al. Uremic toxins: do we know enough to explain uremia?
Neirynck et al. An update on uremic toxins
Tao et al. Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study
US11529445B2 (en) Methods and apparatus for kidney dialysis and extracorporeal detoxification
Böhringer et al. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration
US20070251882A1 (en) Method of removing antibody free light chains from blood
EP2577270A1 (en) Method and device for measuring and monitoring concentration of substances in a biological fluid
Winchester et al. Unresolved issues in dialysis: extracorporeal strategies for the removal of middle molecules
Vanholder et al. From uremic toxin retention to removal by convection: do we know enough?
Vanholder et al. New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy
Panichi et al. Post‐Dilution on Line Haemodiafiltration with Citrate Dialysate: First Clinical Experience in Chronic Dialysis Patients
Etinger et al. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes
Sternkopf et al. A bifunctional adsorber particle for the removal of hydrophobic uremic toxins from whole blood of renal failure patients
Bonomini et al. Examining hemodialyzer membrane performance using proteomic technologies
Hyšpler et al. Indoxyl sulfate elimination in renal replacement therapy: influence of citrate‐versus acetate‐buffering component during bicarbonate dialysis
Nakada et al. Blood purification for hypercytokinemia
Colombo et al. Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis
AU2011274009B2 (en) A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid
Molina et al. Combining diffusion, convection and absorption: a pilot study of polymethylmethacrylate versus polysulfone membranes in the removal of P-cresyl sulfate by postdilution on-line hemodiafiltration
Krieter et al. Clinical performance comparison of two medium cut‐off dialyzers
JP2012112785A (en) Evaluation method of dialysis membrane